Dong-A crowned as top drug maker

Published: 2011-02-10 07:00:00

Updated: 2011-02-10 07:00:00

Dong-A Pharmaceutical has boasted the highest annual revenue in Korea’s competitive pharmaceutical market for the last 40 years. But last year, the company’s market leadership was being challenged by rival Green Cross whose net profit jumped 267 percent in the first half of 2010 from the same per...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK